Boston Scientific Settles 14 Stent Patent Suits With J&J For $716 Million
This article was originally published in The Gray Sheet
Executive Summary
Long-time stent rivals Boston Scientific and Johnson & Johnson signed a partial patent détente Sept. 29, but the companies are not finished battling over intellectual property for the profitable devices